IL-HYATT-HOTELS
14.7.2022 14:02:11 CEST | Business Wire | Press release
To share progress made across World of Care, the company’s Environmental, Social and Governance (ESG) platform, Hyatt Hotels Corporation (NYSE: H) today published its 2021 World of Care Highlights and Diversity, Equity and Inclusion (DE&I) Report to demonstrate how Hyatt is advancing care for the planet, people and responsible business.
“Caring for people so they can be their best has been at the core of Hyatt’s story for 65 years. Through World of Care, we embrace our responsibility and opportunity to work together to shape a more sustainable world and future,” said Margaret Egan, executive vice president and general counsel, Hyatt. “By intently focusing on driving progress against key ESG commitments like our environmental framework and Change Starts Here goals, we are holding ourselves accountable for continued action and progress in order to create the needed changes for our industry, society and planet.”
Hyatt Advances Diverse Workforce Representation
Following last year’s inaugural DE&I report, Hyatt’s 2021 workforce diversity data shows increased levels of representation of people of color across its U.S. workforce, as well as growth across nearly all races and ethnicities among colleagues, managers and leaders. Hyatt’s commitment to share progress annually serves as a critical benchmark to measure the strides made toward a more diverse, equitable and inclusive environment for colleagues.
Hyatt continues to work toward its 2025 DE&I goals around who it employs, supports and works with, outlined as part of its Change Starts Here commitments. With a focus on improving diverse vendor representation across its supply chain, Hyatt welcomed 220 new Black suppliers in 2021, with a continued focus on advancing progress looking ahead. For example, Revival Baltimore, which is part of the JdV by Hyatt brand, worked with Black-owned Black Acres Roastery to supply coffee to all hotel guestrooms and the property’s onsite coffee shop, ‘Dashery, and Hyatt Centric The Pike Long Beach recently welcomed Black-owned brewery Crowns & Hops to its Watercraft Lounge.
“At Hyatt, we believe in the power of belonging – of making people feel at home no matter where they are in the world. We constantly strive to reflect the world we care for with teams that achieve and grow together,” said Malaika Myers, chief human resources officer, Hyatt. “To advance our vision of a world of understanding and care, we must continue to prioritize DE&I across every dimension of our business and take action to make meaningful progress against our goals.”
Hyatt Announces Donation to Launch Human Trafficking Survivor Fund
In an effort to expand the hotel industry’s ongoing work to support human trafficking prevention and survivors, the Hyatt Hotels Foundation has announced a $500,000 donation to launch the “No Room for Trafficking Survivors Fund” in collaboration with the American Hotel & Lodging Association (AHLA). With the donation, and further support from the industry, the Survivors Fund will equip community-based organizations with the resources they need to engage and support survivors – from direct financial support of their short-term, baseline needs to career-related support that can empower and equip them on their path forward.
Hyatt Works to Advance Climate Action
Hyatt further accelerates its efforts to engage in more sustainable business practices as part of its environmental framework – focused on areas of climate change and water conservation, waste and circularity, responsible sourcing and thriving destinations.
In 2021, Hyatt received approval from the Science Based Targets initiative (SBTi) on its 2030 science-based target to reduce greenhouse gas emissions. Hyatt’s targets include reducing absolute scope 1 and 2 emissions, engaging key suppliers to set science-based targets by 2025, and decreasing additional scope 3 emissions.
Hyatt remains diligent in promoting initiatives that support progress toward its science-based target, which focus on energy conservation, efficient technology, building automation systems, advancing sustainable design considerations and more. An important ongoing focus will be on increasing the number of hotels that have on-site solar panels or are using one-hundred percent renewable electricity such as Hyatt Regency Amsterdam and Hyatt Regency Phoenix. Ongoing property efforts are also critical in achieving these targets, such as the ones displayed at Alila Villas Uluwatu through its on-site sustainability lab .
To learn more about Hyatt’s ESG efforts and progress, visit Hyatt.com/WorldofCare or browse the 2021 World of Care Highlights , 2021 DE&I Report and 2021 GRI Index .
The term “Hyatt” is used in this release for convenience to refer to Hyatt Hotels Corporation and/or one or more of its affiliates.
About Hyatt Hotels Corporation
Hyatt Hotels Corporation, headquartered in Chicago, is a leading global hospitality company guided by its purpose – to care for people so they can be their best. As of March 31, 2022, the Company’s portfolio included more than 1,150 hotels and all-inclusive properties in 71 countries across six continents. The Company's offering includes the Park Hyatt®, Miraval®, Grand Hyatt®, Alila®, Andaz®, The Unbound Collection by Hyatt®, Destination by Hyatt™, Hyatt Regency®, Hyatt®, Hyatt Ziva™, Hyatt Zilara™, Thompson Hotels®, Hyatt Centric®, Caption by Hyatt, JdV by Hyatt™, Hyatt House®, Hyatt Place®, UrCove, and Hyatt Residence Club® brands, as well as resort and hotel brands under the AMR™ Collection, including Secrets® Resorts & Spas, Dreams® Resorts & Spas, Breathless Resorts & Spas®, Zoëtry® Wellness & Spa Resorts, Vivid Hotels & Resorts®, Alua Hotels & Resorts®, and Sunscape® Resorts & Spas. Subsidiaries of the Company operate the World of Hyatt® loyalty program, ALG Vacations®, Unlimited Vacation Club®, Amstar DMC destination management services, and Trisept Solutions® technology services. For more information, please visit www.hyatt.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005967/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
